1. Synthesis and Biological Evaluation of Benzo [4,5]- and Naphtho[2′,1′:4,5]imidazo[1,2-c]pyrimidinone Derivatives.
- Author
-
Kamzeeva, Polina, Dagaev, Nikolai, Lizunova, Sofia, Khodarovich, Yuri, Sogomonyan, Anna, Kolchanova, Anastasia, Pokrovsky, Vadim, Alferova, Vera, Chistov, Alexey, Eshtukov-Shcheglov, Artur, Eshtukova-Shcheglova, Elizaveta, Belyaev, Evgeny, Skvortsov, Dmitry, Varizhuk, Anna, and Aralov, Andrey
- Subjects
BIOSYNTHESIS ,POISONS ,IMIDAZOPYRIDINES ,DRUG target ,BODY weight ,ANTINEOPLASTIC agents ,ONCOGENES - Abstract
Azacarbazoles have attracted significant interest due to their valuable properties, such as anti-pathogenic and antitumor activity. In this study, a series of structurally related tricyclic benzo[4,5]- and tertacyclic naphtho[2′,1′:4,5]imidazo[1,2-c]pyrimidinone derivatives with one or two positively charged tethers were synthesized and evaluated for anti-proliferative activity. Lead tetracyclic derivative 5b with two amino-bearing arms inhibited the metabolic activity of A549 lung adenocarcinoma cells with a CC
50 value of 3.6 μM, with remarkable selectivity (SI = 17.3) over VA13 immortalized fibroblasts. Cell-cycle assays revealed that 5b triggers G2/M arrest without signs of apoptosis. A study of its interaction with various DNA G4s and duplexes followed by dual luciferase and intercalator displacement assays suggests that intercalation, rather than the modulation of G4-regulated oncogene expression, might contribute to the observed activity. Finally, a water-soluble salt of 5b was shown to cause no acute toxic effects, changes in mice behavior, or any decrease in body weight after a 72 h treatment at concentrations up to 20 mg/kg. Thus, 5b is a promising candidate for studies in vivo; however, further investigations are needed to elucidate its molecular target(s). [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF